Davinthra Thillainathan
Stock Analyst at Goldman Sachs
(1.98)
# 3,257
Out of 5,032 analysts
37
Total ratings
43.5%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Davinthra Thillainathan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Upgraded: Buy | $54.10 | $54.55 | -0.82% | 5 | Aug 27, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Downgraded: Sell | $3.30 → $2.08 | $2.82 | -26.24% | 2 | Aug 6, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Upgraded: Hold | $2.10 → $2.15 | $2.14 | +0.47% | 2 | Jun 1, 2026 | |
| ASX: ANN Ansell Limited | Initiated Coverage: Hold | $31.80 | $45.50 | -30.11% | 1 | Apr 7, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $53.11 → $54.72 | $47.00 | +16.42% | 5 | Feb 23, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $49.30 → $53.20 | $31.90 | +66.77% | 9 | Feb 2, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $304.60 → $212.10 | $181.99 | +16.54% | 5 | Oct 29, 2025 | |
| ASX: NAN Nanosonics Limited | Initiated Coverage: Buy | $7.06 | $2.90 | n/a | 1 | Sep 25, 2025 | |
| ASX: HLS Healius Limited | Reiterated: Sell | $1.20 → $0.80 | $0.41 | n/a | 2 | Aug 12, 2025 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | n/a | $129.50 | n/a | 4 | Jun 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32.20 | $18.83 | n/a | 1 | Apr 3, 2025 |
Ramsay Health Care Limited
Aug 27, 2026
Upgraded: Buy
Price Target: $54.10
Current: $54.55
Upside: -0.82%
Australian Clinical Labs Limited
Aug 6, 2026
Downgraded: Sell
Price Target: $3.30 → $2.08
Current: $2.82
Upside: -26.24%
Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10 → $2.15
Current: $2.14
Upside: +0.47%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $45.50
Upside: -30.11%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Reiterated: Buy
Price Target: $53.11 → $54.72
Current: $47.00
Upside: +16.42%
ResMed Inc.
Feb 2, 2026
Reiterated: Buy
Price Target: $49.30 → $53.20
Current: $31.90
Upside: +66.77%
CSL Limited
Oct 29, 2025
Reiterated: Buy
Price Target: $304.60 → $212.10
Current: $181.99
Upside: +16.54%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $7.06
Current: $2.90
Upside: n/a
Healius Limited
Aug 12, 2025
Reiterated: Sell
Price Target: $1.20 → $0.80
Current: $0.41
Upside: n/a
Cochlear Limited
Jun 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $129.50
Upside: n/a
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $18.83
Upside: n/a